RxDoctor Payments Data

Arshad Quadri

Thoracic Surgery (Cardiothoracic Vascular Surgery) · W. Hartford, CTNPI 1942292057

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $576,620 of the $626,297 with a category attached, or 92.1%. Edwards Lifesciences accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $626,253 and has fallen 100.0% since, to $23 in 2024. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$626,297in general payments, 2019–2025

Across 11 payments — averaging $56,936 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$626K
  • Abbott$23
  • GSK$21

What the payments were for

  • Royalty or licence$576,62092%
  • Consulting fees$34,0005%
  • Travel & lodging$15,1342%
  • Food & beverage$5430%

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences9$626,253
Abbott1$23
GSK1$21

How this compares

$626,297 in reported general payments places this provider in the 95th percentile of 70 thoracic surgery (cardiothoracic vascular surgery) providers in Connecticut.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Connecticut

Other thoracic surgery (cardiothoracic vascular surgery) in W. Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →